Labeling Changes Proposed for Rx Drugs Used During Pregnancy, Breastfeeding
FDA has proposed major revisions to physician labeling for prescription drugs (including biological products) to provide better information about the effects of medicines used during pregnancy and breastfeeding. The changes would give health care professionals more comprehensive information for making prescribing decisions and for counseling women about using prescription medications if they are pregnant, breastfeeding, or of childbearing age.
No comments:
Post a Comment